معرفی
Dr. Shari Messinger is a Professor of Biostatistics in the Department of Public Health Sciences at the University of Miami Miller School of Medicine. Since 2002 she has directed the Division of Biostatistics, the Biostatistics Collaboration and Consulting Core, and the Research Design and Biostatistics Program of the Miami Clinical and Translational Science Institute (CTSI).
Education
- PhD in Biostatistics, University of Michigan School of Public Health, 2002
- MS in Biostatistics, University of Michigan School of Public Health, 1998
- Other studies in Industrial and Systems Engineering, University of Florida, 1996
- BS in Industrial and Systems Engineering, University of Florida, 1994
Research Focus
Dr. Messinger’s scholarship centers on the intersection of advanced biostatistical methods and diabetes research. She brings deep expertise in clinical-trial design, observational-study analysis, and the application of sophisticated statistical techniques to complex biomedical data. Her work supports both mechanistic investigations and large-scale translational projects, ensuring rigorous evidence generation across the University of Miami’s research enterprise.
Scientific Awards & Honors
- Lecturer of the Year – PHSA, University of Miami
- NIH Clinical Loan Repayment Program Recipient (2004–2008)
- Multiple travel and dissertation awards from ENAR, ASA, and the University of Michigan
- Horace H. Rackham Pre-Doctoral Fellowship (2000–2001)
Leadership & Service
As Director of three interlinked biostatistics units, Dr. Messinger oversees a multidisciplinary team that provides study-design consultation, data-analysis support, and statistical education to investigators throughout the university and its affiliated hospitals. She has served on review panels for NIH, the Juvenile Diabetes Research Foundation, and leading journals such as the Journal of Cardiac Surgery and the British Medical Journal. Her long-standing involvement in the CTSA consortium’s Biostatistics, Epidemiology, and Research Design group further amplifies her national impact on translational research infrastructure.
